Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase
Author:
Affiliation:
1. Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm800043g
Reference12 articles.
1. Tyrosine kinase receptor indistinguishable from the c-met protein
2. Met, metastasis, motility and more
3. Hereditary Papillary Renal Carcinoma Type I
4. MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
5. Targeting Tyrosine Kinases in Cancer: The Second Wave
Cited by 130 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Novel 3,6-Disubstituted Pyridazine Derivatives Targeting JNK1 Pathway: Scaffold Hopping and Hybridization-Based Design, Synthesis, Molecular Modeling, and In Vitro and In Vivo Anticancer Evaluation;ACS Omega;2024-08-19
2. 1,3-Disubstituted-1,2,4-triazin-6-ones with potent activity against androgen receptor-dependent prostate cancer cells;Bioorganic & Medicinal Chemistry;2024-03
3. Targeting MET: Discovery of Small Molecule Inhibitors as Non-Small Cell Lung Cancer Therapy;Journal of Medicinal Chemistry;2023-06-01
4. Molecular and Biological Investigation of Isolated Marine Fungal Metabolites as Anticancer Agents: A Multi-Target Approach;Metabolites;2023-01-21
5. A new triazolothiadiazine derivative inhibits stemness and induces cell death in HCC by oxidative stress dependent JNK pathway activation;Scientific Reports;2022-09-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3